VSee Health, Inc. Payments to Acquire Productive Assets
VSee Health, Inc. (VSEE) reported Payments to Acquire Productive Assets of $26.75 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2026-05-15
- VSee Health, Inc. payments to acquire productive assets for the quarter ending 2026-03-31 was $26.75K, a 125.32% increase year-over-year.
- VSee Health, Inc. payments to acquire productive assets for the quarter ending 2025-12-31 was $7.15K, a 50.25% increase year-over-year.
- VSee Health, Inc. payments to acquire productive assets for the quarter ending 2025-03-31 was $11.87K, a 35.85% increase year-over-year.
- VSee Health, Inc. payments to acquire productive assets for the quarter ending 2024-12-31 was $4.76K, a 189.36% increase year-over-year.
- VSee Health, Inc. payments to acquire productive assets for fiscal 2025 was $29.93K, a 45.85% decline from fiscal 2024.
- VSee Health, Inc. payments to acquire productive assets for fiscal 2024 was $55.27K, a 1174.90% increase from fiscal 2023.
- VSee Health, Inc. payments to acquire productive assets for fiscal 2023 was $4.33K.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 12 month |
|---|---|---|---|---|
| 2026-03-31 | $26.75K 10-Q · filed 2026-05-15 | $33.90K derived: sum of 2 quarters · filed 2026-05-15 | ||
| 2025-12-31 | $7.15K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $29.93K 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $22.78K 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | $15.47K 10-Q/A · filed 2025-11-20 | |||
| 2025-03-31 | $11.87K 10-Q · filed 2026-05-15 | $16.63K derived: sum of 2 quarters · filed 2026-05-15 | $21.63K derived: sum of 3 quarters · filed 2026-05-15 | $58.40K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $4.76K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $9.75K derived: sum of 2 quarters · filed 2026-03-31 | $46.53K derived: sum of 3 quarters · filed 2026-03-31 | $55.27K 10-K · filed 2026-03-31 |
| 2024-09-30 | $4.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $41.77K derived: sum of 2 quarters · filed 2025-11-14 | $50.51K 10-Q · filed 2025-11-14 | $52.15K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $36.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-09-23 | $45.51K 10-Q · filed 2024-09-23 | $47.16K derived: sum of 3 quarters · filed 2025-10-15 | $45.51K 10-Q/A · filed 2025-11-20 |
| 2024-03-31 | $8.74K 10-Q · filed 2025-10-15 | $10.38K derived: sum of 2 quarters · filed 2025-10-15 | $10.38K derived: sum of 3 quarters · filed 2025-10-15 | |
| 2023-12-31 | $1.65K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-29 | $1.65K derived: sum of 2 quarters · filed 2025-08-29 | $4.33K 10-K/A · filed 2025-08-29 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $2.69K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $2.69K 10-Q · filed 2024-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |